The Endometrial Receptivity Array (ERA) is a diagnostic tool used in fertility
treatment to assess the receptivity of the endometrium, the lining of the uterus, for embryo implantation. The ERA test involves taking a small biopsy of the
endometrium during a woman's menstrual cycle and analyzing the genetic
expression of certain genes to determine the optimal time for embryo transfer.

The ERA test is typically recommended for women who have experienced repeated implantation failure during IVF or other fertility treatments. It can help to identify any potential issues with the timing of embryo transfer, which may be contributing to the failure of the embryo to implant in the uterus.

The ERA test involves the analysis of a set of genes that are known to be involved in the process of embryo implantation. By analyzing the genetic expression of these genes, the test can determine the precise window of time during the menstrual cycle when the endometrium is most receptive to embryo implantation.

If the test shows that the woman endometrium is receptive at a different time than expected based on the standard menstrual cycle, the fertility specialist can adjust the timing of embryo transfer accordingly. This can potentially increase the chances of a successful pregnancy.

Overall, the ERA test is a useful tool for fertility specialists to help identify any issues with endometrial receptivity that may be contributing to implantation failure and to optimize the timing of embryo transfer for the best chance of success.

Usually single or double iui is performed based on the nature of the problem.The patient is made to lie down for 15-20 minutes after the IUI and normal physical
activities can be resumed after the IUI. 

This can improve the chances of fertilization and pregnancy by bringing the sperm closer to the egg at the fallopian tubes where they can chemically communicate.Upto 3-6 IUI’s can be tried by the couple based on the reserve,tubal status,sperm quality.

Ovulation induction and IUI are often used together as a fertility treatment. In this case, the woman is given medication to stimulate the growth of follicles in the ovaries, and then the IUI procedure is performed around the time of ovulation to increase the chances of the sperm fertilizing the egg.

Ovarian reserve testing is a medical evaluation that helps determine a woman's fertility potential. This testing involves assessing the quantity of a woman's remaining eggs in her ovaries.

There are several methods used for ovarian reserve testing, including blood tests that measure hormone levels such as follicle-stimulating hormone (FSH), and anti mullerian hormone (AMH). These hormones are used as markers of ovarian function and can help predict the number of remaining eggs a woman has AMH has been
accurate in measuring the ovarian reserve with good reproducibility.

AFC-Antral follicle count is an important method for ovarian reserve testing.Here
ultrasound is used , which can measure the size and number of follicles in the
ovaries. This test is done between 2-5 days of the menstrual cycle and is one of the most accurate methods to test the ovarian reserve.